cytarabine and 3-methyladenine

cytarabine has been researched along with 3-methyladenine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borutaite, V; Tolkovsky, AM; Xue, L1
Barbosa, CM; Bincoletto, C; Jurkiewicz, A; Palmeira dos Santos, C; Pereira, GJ; Smaili, SS1
Ajami, M; Anjam-Najmedini, A; Atashi, A; Houshmand, M; Kazemi, A; Ojaghi, M; Sadri, M; Tavakoli, R; Yazdi, N; Zarif, MN1

Other Studies

3 other study(ies) available for cytarabine and 3-methyladenine

ArticleYear
Inhibition of mitochondrial permeability transition and release of cytochrome c by anti-apoptotic nucleoside analogues.
    Biochemical pharmacology, 2002, Aug-01, Volume: 64, Issue:3

    Topics: Adenine; Animals; Arabinofuranosylcytosine Triphosphate; Cytarabine; Cytochrome c Group; Drug Interactions; Enzyme Inhibitors; Ion Channels; Kinetin; Male; Mitochondria, Heart; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Nucleic Acid Synthesis Inhibitors; Purines; Rats; Rats, Wistar

2002
Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine‑induced death of leukaemia cells.
    Journal of cancer research and clinical oncology, 2014, Volume: 140, Issue:6

    Topics: Adenine; Antimalarials; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Blotting, Western; Caspase 3; Cell Proliferation; Chloroquine; Cytarabine; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunophenotyping; Leukemia; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Tumor Cells, Cultured; Tumor Stem Cell Assay

2014
The anticancer effects of pharmacological inhibition of autophagy in acute erythroid leukemia cells.
    Anti-cancer drugs, 2018, Volume: 29, Issue:10

    Topics: Adenine; Antimetabolites, Antineoplastic; Autophagy; Cell Line, Tumor; Chloroquine; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cytarabine; Down-Regulation; G1 Phase; Humans; Leukemia, Erythroblastic, Acute; MicroRNAs; Resting Phase, Cell Cycle; Up-Regulation

2018